REGISTERED NUMBER: |
Unaudited financial statements for the year ended 30 June 2024 |
For |
Medi Invest Ltd |
REGISTERED NUMBER: |
Unaudited financial statements for the year ended 30 June 2024 |
For |
Medi Invest Ltd |
Medi Invest Ltd (Registered number: 08111486) |
Contents of the financial statements |
for the year ended 30 June 2024 |
Page |
Company information | 1 |
Balance sheet | 2 |
Notes to the financial statements | 3 |
Medi Invest Ltd |
Company information |
for the year ended 30 June 2024 |
Directors: |
Secretary: |
Registered office: |
Registered number: |
Accountants: |
15a Harbour Road |
Inverness |
INVERNESS-SHIRE |
IV1 1SY |
Medi Invest Ltd (Registered number: 08111486) |
Balance sheet |
30 June 2024 |
2024 | 2023 |
Notes | € | € |
Current assets |
Debtors | 5 |
Cash at bank |
Creditors |
Amounts falling due within one year | 6 | ( |
) | ( |
) |
Net current assets |
Total assets less current liabilities |
Capital and reserves |
Called up share capital | 7 |
Retained earnings |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the Board of Directors and authorised for issue on |
Medi Invest Ltd (Registered number: 08111486) |
Notes to the financial statements |
for the year ended 30 June 2024 |
1. | Statutory information |
The principal activity of Medi Invest Ltd is that of a business introducer and development in the field of import and distribution of pharmaceutical products. |
The company is a private company limited by shares and incorporated in the UK. Its registered office is Suite 1, 7th Floor, 50 Broadway, London, SW1H 0BL, United Kingdom. The company's registered number is 8111486. |
The financial statements are presented in Euro, which is the functional currency of the company. |
The company has no employees. |
2. | Statement of compliance |
3. | Accounting policies |
Basis of preparing the financial statements |
These financial statements are prepared on a going concern basis, under the historical cost convention, as modified by the revaluation of certain financial assets and liabilities measured at for value through the statement of comprehensive income. |
General revenue |
General revenue is accounted for on a receivable basis. |
Expenses |
Expenses are recognised on an accruals basis |
Foreign Currency |
Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. |
At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. |
Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the statement of comprehensive income. |
Taxation |
Taxation expense for the period where applicable comprises current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income. |
4. | Employees and directors |
The average number of employees during the year was NIL (2023 - NIL). |
Medi Invest Ltd (Registered number: 08111486) |
Notes to the financial statements - continued |
for the year ended 30 June 2024 |
5. | Debtors: amounts falling due within one year |
2024 | 2023 |
€ | € |
Debtor - Bio Sidus SA | 2,987,567 | 1,951,114 |
Debtor - cash advances - Belingate Overseas Ltd | - | 750 |
Shareholder loan | 1 | 1 |
Prepayments | 2,971 | 3,267 |
2,990,539 | 1,955,132 |
The Shareholder loan receivable is unsecured, interest free and repayable on demand. |
6. | Creditors: amounts falling due within one year |
2024 | 2023 |
€ | € |
Gross margin | 3,008,173 | 2,053,734 |
Vendor - Vistra trust | 1,053 | - |
Accruals | 3,163 | 3,609 |
Tax | 5,766 | - |
3,018,155 | 2,057,343 |
7. | Called up share capital |
2024 | 2023 |
€ | € |
1 Ordinary share of £1 |
Allotted, called up and fully paid |
At 1 July and 30 June | 1 | 1 |
The Company has one class of ordinary shares. |